SOADOR
VNDA icon

State of Alaska Department of Revenue’s Vanda Pharmaceuticals VNDA Stock Holding History

State of Alaska Department of Revenue’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-37,797
Closed -$249K – 1628
2023
Q2 		$249K Sell
37,797
-1,088
-3% -$6.97K ﹤0.01% 1577
2023
Q1 		$264K Sell
38,885
-520
-1% -$3.66K ﹤0.01% 1569
2022
Q4 		$291K Buy
39,405
+246
+0.6% +$2.4K ﹤0.01% 1548
2022
Q3 		$386K Sell
39,159
-3,569
-8% -$37.7K 0.01% 1432
2022
Q2 		$465K Buy
42,728
+3,970
+10% +$41.1K 0.01% 1388
2022
Q1 		$438K Sell
38,758
-690
-2% -$9.07K ﹤0.01% 1444
2021
Q4 		$618K Sell
39,448
-1,140
-3% -$19.9K 0.01% 1345
2021
Q3 		$695K Buy
40,588
+2,145
+6% +$37.6K 0.01% 1298
2021
Q2 		$826K Buy
38,443
+1,287
+3% +$23K 0.01% 1183
2021
Q1 		$558K Sell
37,156
-5,410
-13% -$87.6K 0.01% 1379
2020
Q4 		$559K Sell
42,566
-8,570
-17% -$103K 0.01% 1302
2020
Q3 		$493K Sell
51,136
-30
-0.1% -$321 0.01% 1244
2020
Q2 		$585K Buy
51,166
+1,690
+3% +$19.1K 0.01% 1162
2020
Q1 		$512K Buy
49,476
+9,200
+23% +$114K 0.01% 1092
2019
Q4 		$660K Sell
40,276
-590
-1% -$8.92K 0.01% 1161
2019
Q3 		$542K Buy
40,866
+22,836
+127% +$318K 0.01% 1228
2019
Q2 		$254K Buy
18,030
+288
+2% +$4.58K ﹤0.01% 1373
2019
Q1 		$326K Buy
17,742
+165
+0.9% +$3.76K 0.01% 1278
2018
Q4 		$459K Buy
17,577
+150
+0.9% +$3.53K 0.01% 1011
2018
Q3 		$399K Buy
+17,427
New +$356K 0.01% 1224

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State of Alaska Department of Revenue's VNDA Position: Q3 2023 in Review

State of Alaska Department of Revenue sold out of Vanda Pharmaceuticals (VNDA) in Q3 2023, closing a stake of 37,797 shares — an estimated $249K sold.

State of Alaska Department of Revenue first reported a position in VNDA in Q3 2018 and held it in 20 quarters. The position peaked at $826K in Q2 2021. 179 funds tracked by Wall St. Rank hold VNDA as of Q3 2023.

  • State of Alaska Department of Revenue reported no remaining Vanda Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • State of Alaska Department of Revenue sold 37,797 Vanda Pharmaceuticals shares in Q3 2023, an estimated $249K.
  • State of Alaska Department of Revenue first reported a position in Vanda Pharmaceuticals in Q3 2018 and held it in 20 quarters.
  • State of Alaska Department of Revenue's Vanda Pharmaceuticals position peaked at $826K in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2023.

Based on State of Alaska Department of Revenue's 13F filing for Q3 2023, filed 16 Oct 2023.